RMB / Molee ..they probably have made progress enrolling patients in their trial . I'll look for an update on clinical trials .gov . P3 results still due this yr Kiwi
I listened to their CC. Multiple sites have now been signed up and are screening patients . No one has completed the trial yet ...so total completion is pushed off till end of year ( my guess ) Have $14m in cash and will burn thru much of that running this trial ...so renegotiating mile stone payment with Nantahala will be key in Sept . Nantahala now has some one on the BOD. New CMO ? is a Nephrologist and may be able to expedite the clinical trial site set ups / enrollment faster
Another Co besides UNCY thats difficult to be patient with . The pivotal clinical trial for TLPH has been painfully slow to enroll ...while they burn thru their cash on hand
Hopefully stock will stay above $1 for 10 days and cure its delisting notice
To regain compliance, the stock must trade at or above $1 for a minimum of 10 consecutive business days
Co will have to renegotiate the timing of a progress payment ....originally a payment was to be made if their pivotal trial was fully enrolled by Sept 30 th ...looks unlikely altho not impossible
Market Data 
Markets 
AI
